Literature DB >> 25840979

Methods of CT Dose Estimation in Whole-Body ¹⁸F-FDG PET/CT.

Yusuke Inoue1, Kazunori Nagahara2, Yoshihito Tanaka2, Hiroki Miyatake2, Hirofumi Hata2, Toshimasa Hara3.   

Abstract

UNLABELLED: We evaluated the effective dose (ED) of the CT component of whole-body PET/CT using software dedicated to CT dose estimation and from dose-length product (DLP) values to establish practical methods of ED estimation.
METHODS: Eighty adult patients who underwent (18)F-FDG whole-body PET/CT were divided into groups A and B, each consisting of 20 men and 20 women. In group A, ED of the CT component was calculated using CT-Expo for 6 anatomic regions separately, and whole-body ED was obtained by summing the regional EDs (CT-Expo method). DLP was calculated for each of the 6 regions and multiplied by a corresponding conversion factor described in International Commission on Radiological Protection publication 102 to obtain the ED for each region (regional DLP method). Whole-body ED was also calculated as the product of a whole-body DLP value provided by the scanner automatically and a conversion factor (simple DLP method). Moreover, the ED/DLP values were calculated using whole-body ED estimated by the CT-Expo method and the scanner-derived DLP, to optimize the conversion factor. In group B, the optimized conversion factor was applied for the estimation of ED by the simple DLP method.
RESULTS: In group A, the regional DLP method allowed an accurate estimation of mean whole-body ED as a result of counterbalance of mild overestimation in men and mild underestimation in women, regarding the CT-Expo method as a standard. The simple DLP method using a conversion factor for the trunk (0.015 mSv/mGy/cm) caused overestimation. On the basis of the ED/DLP values in group A, a modified conversion factor of 0.013 mSv/mGy/cm and sex-specific conversion factors of 0.012 and 0.014 mSv/mGy/cm for men and women, respectively, were determined. In group B, the use of the modified conversion factor improved accuracy, and the use of sex-specific conversion factors eliminated sex-dependent residual errors.
CONCLUSION: ED of the CT component of whole-body PET/CT can be assessed by multiplying the scanner-derived DLP by a conversion factor optimized for whole-body PET/CT.
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  CT; PET/CT; dose-length product; effective dose; radiation exposure

Mesh:

Substances:

Year:  2015        PMID: 25840979     DOI: 10.2967/jnumed.114.153718

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  CT dose modulation using automatic exposure control in whole-body PET/CT: effects of scout imaging direction and arm positioning.

Authors:  Yusuke Inoue; Kazunori Nagahara; Hiroko Kudo; Hiroyasu Itoh
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

2.  Embryo/Fetus Doses from 18F-Fludeoxyglucose Radiopharmaceutical in Positron Emission Tomography/ Computed Tomography.

Authors:  Nazenin İpek Işıkçı; Mustafa Demir
Journal:  J Med Phys       Date:  2022-03-31

3.  Justification of whole-body CT in polytrauma patients, can clinical examination help selecting patients?

Authors:  Richa Arora; Abhishek J Arora
Journal:  Quant Imaging Med Surg       Date:  2019-04

4.  An evaluation of DNA double strand break formation and excreted guanine species post whole body PET/CT procedure.

Authors:  Tanmoy Mondal; Amit Nautiyal; Somiranjan Ghosh; Christopher A Loffredo; Deepanjan Mitra; Chabita Saha; Subrata Kumar Dey
Journal:  J Radiat Res       Date:  2021-07-10       Impact factor: 2.724

5.  National Diagnostic Reference Level (DRL) for nuclear medicine computed tomography-positron emission tomography hybrid imaging studies for kuwait population: second phase dose audit-2019.

Authors:  Michael Masoomi; Iman Al-Shammeri; Latifah Al-Kandari; Hany Elrahman; Jehan Al-Shammeri
Journal:  BJR Open       Date:  2021-11-24

6.  Effective dose estimation for oncological and neurological PET/CT procedures.

Authors:  Josep M Martí-Climent; Elena Prieto; Verónica Morán; Lidia Sancho; Macarena Rodríguez-Fraile; Javier Arbizu; María J García-Velloso; José A Richter
Journal:  EJNMMI Res       Date:  2017-04-24       Impact factor: 3.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.